Mumbai, April 30 -- Gland Pharmahas received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for Latanoprostene Bunod Ophthalmic Solution, 0.024%.

Published by HT Digital Content Services with permission from Capital Market....